Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 15, 2026 09:00 ET | Source: Recor Medical

Recor Medical Highlights Innovation and Global Action on World Hypertension Day 2026

Palo Alto, CA, May 15, 2026 (GLOBE NEWSWIRE) -- In recognition of World Hypertension Day 2026, Recor Medical, Inc. (“Recor”), a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., joins the...
May 07, 2026 08:05 ET | Source: Scienture Holdings, Inc.

Scienture Secures $11.0 Million in Non-Dilutive Debt Financing to Accelerate Growth of Approved Product Portfolio and Advancement of R&D Pipeline

Proceeds support commercialization of Arbli™, the first FDA-approved ready-to-use oral suspension for hypertension; and REZENOPY™, life-saving opioid overdose emergency treatment Financing also...
May 06, 2026 09:49 ET | Source: ESO Solutions, Inc.

2026 ESO EMS Index Finds One in Five EMS Patients Drives Nearly Half of All 911 Responses

ESO released the 2026 ESO EMS Index, the annual benchmark for prehospital care built on the industry’s largest integrated emergency outcome data asset.
April 22, 2026 17:00 ET | Source: George Medicines

George Medicines: New England Journal of Medicine publishes global stroke outcomes trial that demonstrated reduction of risk for recurrent stroke by almost 40% with GMRx2 in patients with previous intracerebral hemorrhage

Significant lowering of systolic blood pressure of 9mmHg on top of background treatment maintained with GMRx2 over an average follow-up of 3 years Safety findings similar to previous studies of GMRx2 ...
March 30, 2026 08:07 ET | Source: Scienture Holdings, Inc.

SCIENTURE Reports Year End 2025 Financial Results and Provides Business Update

Reports Significant Revenue Growth and Gross Margin Expansion in 2025 COMMACK, NY, March 30, 2026 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (“Scienture”), a holding company for...
March 13, 2026 13:15 ET | Source: Cohen Milstein Sellers & Toll PLLC

Eve-of-Trial $65M Settlement Preliminarily Approved in Novel Antitrust Class Action Against J&J Subsidiary Actelion Pharmaceuticals

Plaintiffs alleged the anticompetitive scheme forced Tracleer purchasers to pay higher prices and delayed market entry of less-costly generic versions.
March 11, 2026 08:00 ET | Source: George Medicines

George Medicines signs exclusive licensing agreement with Ahngook Pharmaceutical to commercialize GMRx2 in Korea

George Medicines signs exclusive licensing agreement with Ahngook Pharmaceutical to commercialize GMRx2 in Korea GMRx2 is an innovative single pill combination of three medicines designed to deliver...
February 25, 2026 07:00 ET | Source: George Medicines

George Medicines advances its global commercial strategy for GMRx2 with an exclusive licensing agreement with Orient EuroPharma in Southeast Asia

GMRx2 is an innovative single pill combination of three medicines designed to deliver the blood pressure-lowering benefits of triple combination therapy early in the treatment pathway, supported by an...
February 17, 2026 07:00 ET | Source: Essential Pharma

Essential Pharma strengthens rare disease portfolio with acquisition of Ventavis® (iloprost trometamol) for adult primary pulmonary hypertension

Ventavis® is an established inhaled prostacyclin analogue for the treatment of primary pulmonary hypertensionAcquisition reinforces Essential Pharma’s mission to serve the needs of rare disease...
January 28, 2026 04:58 ET | Source: Research and Markets

Global Supraventricular Tachycardia Market to Hit $1 Billion by 2030, Driven by Innovations in Electrophysiology

Dublin, Jan. 28, 2026 (GLOBE NEWSWIRE) -- The "Supraventricular Tachycardia - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for...